NSW Medical Students' Council

  • Increase font size
  • Default font size
  • Decrease font size
Home

NSWMSC Cocktail Party - Tickets Available Now!

Thursday, 04 March 2010 09:59 administrator
E-mail Print PDF
DUE TO SERVER LOAD ISSUES THE BUTTON IS HOSTED BY UWSMS - PLEASE USE LINK AT BASE OF THIS ARTICLE
You and your med friends are invited to the much anticipated NSW Medical Students' Cocktail Party at the Greenwood Hotel (across the road from North Sydney train station).  
 
This is all about having a night to unwind, socialise and mingle with medical students from the 7 major universities from around NSW including Usyd, UNSW, UWS, UNE, Wollongong, Notre Dame and Newcastle.  

Event Details
 
Online tickets are sold out. Some final-release tickets will be available at the door!
  
7:30pm Saturday, 20 March 2010

Greenwood Hotel, 36 Blue St, North Sydney (opposite North Sydney train station) 
Tickets: $10 (This includes a free drink upon arrival. What great value!!).  
  
So, pop the 20th March down in your diary and tell all your friends that this is going to be epic!” 

Conditions of sale: 
You need to print and bring your ticket as a record of your booking! 
You must be 18 to purchase a ticket. ID will be checked.
No refunds.

Last Updated on Thursday, 18 March 2010 11:54  

Polls

I understand what the NSWMSC does for students
 

In the News

Medical news and view for doctors in Australia, updated daily.
  • National registration a reality as WA signs up
    Australia will finally have a national medical registration system next month as WA joins the other states and territories in the National Registration and Accreditation Scheme, the Medical Board of Australia has announced.
  • 65% Pap screen target for PIP payment
    Practices will have to screen 65% of eligible women for cervical cancer from August 2011 to qualify for the $3 PIP payment, up from the current 50% target, Medicare has announced.
  • Call to ban LABA single inhalers for asthma
    Long acting bronchodilators should be banned for use in asthma as single inhaler products because of the increased mortality risk, according to an article in the Lancet.